Search
Hepatitis B Paid Clinical Trials in Alabama
A listing of 1 Hepatitis B clinical trials in Alabama actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 1 of 1
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Hepatitis B
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of Alabama currently has 1 active clinical trials seeking participants for Hepatitis B research studies. These trials are conducted in various cities, including Birmingham, Mobile, Huntsville and Anniston.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Reducing Vertical Transmission of Hepatitis B in Africa
Recruiting
Hepatitis B virus is an infection that can be easily transmitted from women to newborns at the time of delivery. Our objective is to identify novel options that are effective and safe in preventing perinatal transmission of hepatitis B in Africa. The REVERT-B study (Reducing Vertical Transmission of Hepatitis B in Africa) is a clinical trial designed to test a new strategy of using antiviral medication in high-risk pregnant women and newborns to reduce the risk of hepatitis B transmission. The s... Read More
Gender:
FEMALE
Ages:
Between 16 years and 50 years
Trial Updated:
10/16/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Hepatitis B Infection